The perfect fit for your process. CaptureSelect® – custom designed affinity ligands for any purification challenge

CaptureSelect® technology enables new opportunities in the biotherapeutic purification field. BAC has developed a unique affinity ligand discovery program, which has proven itself for a wide variety of target biotherapeutic compounds, ranging from antibodies and antibody fragments, recombinant and plasma proteins to viral particles. CaptureSelect ligands (single domain [VHH] antibody fragments) can be developed for almost any purification challenge, and offer numerous advantages, some of which are listed below.

Click here to download the brochure to find out more about this technology!

About BAC:
BAC BV provides affinity purification products and services for the biopharmaceutical market. Our CaptureSelect products are used for drug discovery upto manufacturing of biopharmaceuticals and are based on a proprietary platform technology, integrating affinity ligand discovery, manufacturing and immobilization of single domain antibodies derived from Camelids. Visit to find out more.

BAC will be exhibiting at BioPharma Asia Convention 2012. Pre-register to visit the exhibition today.

If you are keen to find out more, join us at BioPharma Asia Convention 2012 to gain valuable insights from more than 200 experts. Contact us now for more details!